Ninian N. Lang

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian et al. · European Heart Journal · 2021 · 595 citations · Full text

Medicine, Cardiology, Oncology +16

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)

Matthew M.Y. Lee, Katriona Brooksbank, Kirsty Wetherall et al. · Circulation · 2020 · 437 citations · Full text

Medicine, Cardiology, Pharmacology +17

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 372 citations · Full text

Medicine, Cardiology, Internal Medicine +11

UVA Irradiation of Human Skin Vasodilates Arterial Vasculature and Lowers Blood Pressure Independently of Nitric Oxide Synthase

Donald Liu, Bernadette Fernandez, Alistair Hamilton et al. · Journal of Investigative Dermatology · 2014 · 281 citations · Full text

Medicine, Dermatology, Physiology +12

Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction

Christopher Rush, Colin Berry, Keith G. Oldroyd et al. · JAMA Cardiology · 2021 · 245 citations · Full text

Medicine, Cardiology, Internal Medicine +17